Urolithiasis clinical trials at UCSD
1 research study open to eligible people
open to all eligible people
This study will be a single-institutional randomized, single-blinded prospectively controlled clinical trial of a single dose of Ciprofloxicin 500mg antibiotic tablet as prophylaxis at the time of office flexible cystoscopy with ureteral stent removal. The control group will be no prophylaxis oral antibiotics.
San Diego, California
Our lead scientists for Urolithiasis research studies include Roger L Sur, M.D..